Colossal Foundation

Colossal Tasmanian devil facial tumor.

Colossal Foundation Partners with the University of Tasmania to ‘Give Tasmanian Devils a Fighting Chance’

by | Jul 7, 2026
By using a vaccine and gene editing, the partners aim to fight a lethal cancer that has reduced the wild population of Tasmanian devils by 80% since the 1990s.
MORE
Colossal Targets Extinct Antelope—and Adds a New Branch to its De-Extinction ‘Tree of Life’
by | Apr 30, 2026
At a $10 billion valuation—and spinning out new ventures—Colossal names the bluebuck its sixth de-extinction target, extending its biotech platform into antelope conservation through a global BioVault effort.
MORE

Colossal Foundation Donates $1.5M to Harvard-Based Institute to Advance Artificial Womb Tech for Wildlife Conservation

by | Jan 14, 2025
The funding will support groundbreaking research into artificial womb technologies with the goal of protecting endangered species and advancing wildlife conservation efforts, the foundation said.
MORE
Colossal Launches The Colossal Foundation with $50M for ‘BioVault’ Biobanking, Genetic Rescues, and More
by | Oct 1, 2024
The North Texas-based foundation aims to fight the "extinction crisis" with initiatives including Colossal Biovault—"the world's largest distributed biobanking initiative"—and an array of new efforts to both preserve and "de-extinct" wildlife.
MORE